Surveillance of antibiotic resistance in European ICUs

被引:110
作者
Hanberger, H [1 ]
Diekema, D
Fluit, A
Jones, R
Struelens, M
Spencer, R
Wolff, M
机构
[1] Linkoping Univ Hosp, Dept Infect Dis, S-58185 Linkoping, Sweden
[2] Univ Iowa, Coll Med, Div Med Microbiol, Iowa City, IA USA
[3] Univ Iowa, Coll Med, Div Infect Dis, Iowa City, IA USA
[4] Eijkmann Winkler Inst Microbiol, Utrecht, Netherlands
[5] Free Univ Brussels, Erasme Hosp, Dept Microbiol, B-1050 Brussels, Belgium
[6] Bristol Royal Infirm & Gen Hosp, Publ Hlth Lab, Bristol, Avon, England
[7] Hop Bichat Claude Bernard, Clin Reanimat Malad Infect, F-75877 Paris 18, France
关键词
intensive care units/ICU; antibiotic resistance;
D O I
10.1053/jhin.2001.0987
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
Antibiotic resistance among bacteria causing hospital-acquired infections poses a threat, particularly to patients in intensive care units (ICUs). In order to control the spread of resistant bacteria, local, regional and national resistance surveillance data must be used to develop efficient intervention strategies. In an attempt to identify national differences and the dynamics of antibiotic resistance in European ICUs, data have been merged from several networks of resistance surveillance performed during the 1990s. It should be stressed, however, that comparisons of results from different studies using different methods and different population samples must be made with caution. Antibiotic resistance across all species and drugs Tn-as, with some exceptions, highest in southern European countries and Russia, and lowest in Scandinavia. More effective strategies are needed to control the selection and spread of resistant organisms. Antibiotic intervention policies, efficient infection control measures and an overall awareness of the serious implications at public health level will contribute to the management of antibiotic resistance. (C) 2001 The Hospital Infection Society.
引用
收藏
页码:161 / 176
页数:16
相关论文
共 91 条
[1]
Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in eight hospitals in Turkey [J].
Aksaray, S ;
Dokuzoguz, B ;
Güvener, E ;
Yücesoy, M ;
Yulug, N ;
Kocagöz, S ;
Ünal, S ;
Çetin, S ;
Calangu, S ;
Günaydin, M ;
Leblebicioglu, H ;
Esen, S ;
Bayar, B ;
Willke, A ;
Findik, D ;
Tuncer, I ;
Baysal, B ;
Günseren, F ;
Mamikoglu, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (05) :695-699
[2]
Drug resistance in intensive care units [J].
Albrich, WC ;
Angstwurm, M ;
Bader, L ;
Gärtner, R .
INFECTION, 1999, 27 (Suppl 2) :S19-S23
[3]
Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing [J].
Alfieri, N ;
Ramotar, K ;
Armstrong, P ;
Spornitz, ME ;
Ross, G ;
Winnick, J ;
Cook, DR .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (08) :553-556
[4]
Epidemiology of infections due to multiresistant Enterobacter aerogenes in a university hospital [J].
Allerberger, F ;
Koeuth, T ;
LassFlorl, C ;
Dierich, MP ;
Putensen, C ;
Schmutzhard, E ;
Mohsenipour, I ;
Grundmann, H ;
Hartung, D ;
Bauernfeind, A ;
Eberlein, E ;
Lupski, JR .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (06) :517-521
[5]
Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[6]
Current guidelines for the treatment and prevention of nosocomial infections [J].
Bergogne-Bérézin, E .
DRUGS, 1999, 58 (01) :51-67
[7]
THE INCREASING SIGNIFICANCE OF OUTBREAKS OF ACINETOBACTER SPP - THE NEED FOR CONTROL AND NEW AGENTS [J].
BERGOGNEBEREZIN, E .
JOURNAL OF HOSPITAL INFECTION, 1995, 30 :441-452
[8]
Boyce JM, 1997, INFECT CONT HOSP EP, V18, P622
[9]
BUIRMA RJS, 1991, SCAND J INFECT DIS, V78, pS35
[10]
Antibiotic use and microbial resistance in intensive care units: Impact of computer-assisted decision support [J].
Burke, JP ;
Pestotnik, SL .
JOURNAL OF CHEMOTHERAPY, 1999, 11 (06) :530-535